Search Results for: FORM

The Power of Data Integration: Transforming Oncology Outcomes with Clinical and Genomic Insights

In the world of healthcare, data has become essential to driving better patient outcomes. From clinical records to genomic insights, the convergence of various data sources is revolutionizing research and development (R&D) in pharmaceutical companies. In this article, we will explore the remarkable potential of real-world data (RWD), particularly in oncology, and how its integration […]

Aspira Women’s Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference

Aspira Women’s Health Inc. OVA1Plus® now available to an expanded network of physicians, supporting patients nationwide AUSTIN, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioReference®, an OPKO Health […]

Gestalt Diagnostics’ AI-based digital pathology platform adopted for clinical use by large U.S. lab

The Spokesman-Review Local health sciences company Gestalt Diagnostics says it has achieved a significant milestone by using artificial intelligence and digital pathology to improve patient care. BioReference Laboratories, an OPKO Health company that serves more than 19 million patients per year, has adopted Gestalt Diagnostics’ digital pathology platform in combination with an algorithm developed by […]

BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers

BioReference to also assist with Patient-Centered Data Analytics to SOMOS Providers SOMOS, New York City’s Largest Multi-Cultural Physician-Led Network Selects BioReference as Preferred Provider for Diagnostic Testing MIAMI, FL., July 01, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health (NASDAQ: OPK) company and one of the largest clinical laboratories in the United States, has been selected […]

Labcorp Completes Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses

Labcorp.com BURLINGTON, N.C. and MIAMI, Sept. 15, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp’s acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. This acquisition includes BioReference Health’s laboratory testing businesses focused on oncology […]

Special Coagulation

InsightDx®